BeOne Medicines Ltd. (ONC) has 17 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 11 sales totalling $193.9M. Most recent filing: Sept. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 10, 2026 filed Sept. 8, 2026 | Wang Xiaodong Director | −$2,534,485 | 472,665 | −1% | Yes | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Ball Titus B. Principal Accounting Officer | −$46,974 | 132 | −100% | No | |
|
|
||||||
| Aug. 27, 2026 filed Aug. 25, 2026 | Wu Xiaobin President and COO | −$106,400 | 280 | −100% | Yes | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 11, 2026 | Lee Chan Henry SVP, General Counsel | $919,877 | 39,990 | 0% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | OYLER JOHN Chief Executive Officer | −$86,480,472 | 240,810 | −100% | Yes | |
|
|
||||||
Showing the 5 most recent of 17 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free